BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1360 related articles for article (PubMed ID: 12469454)

  • 21. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic surveillance of Barrett's esophagus. Does it help?
    Streitz JM; Andrews CW; Ellis FH
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):383-7; discussion 387-8. PubMed ID: 8445916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.
    Peters JH; Clark GW; Ireland AP; Chandrasoma P; Smyrk TC; DeMeester TR
    J Thorac Cardiovasc Surg; 1994 Nov; 108(5):813-21; discussion 821-2. PubMed ID: 7967662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction.
    Duhaylongsod FG; Wolfe WG
    J Thorac Cardiovasc Surg; 1991 Jul; 102(1):36-41; discussion 41-2. PubMed ID: 2072727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].
    Peitz U; Malfertheiner P
    Z Gastroenterol; 2007 Dec; 45(12):1264-72. PubMed ID: 18080229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy.
    Abela JE; Going JJ; Mackenzie JF; McKernan M; O'Mahoney S; Stuart RC
    Am J Gastroenterol; 2008 Apr; 103(4):850-5. PubMed ID: 18371135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barrett's esophagus and esophageal cancer.
    Streitz JM
    Chest Surg Clin N Am; 1994 May; 4(2):227-40. PubMed ID: 8049993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Complications of Barrett's esophagus: indications for esophageal resection with special reference to high-grade dysplasia].
    Catrambone G; Leoncini G; Iurilli L; Queirolo A; Spinelli A; Taviani M; Mazzarino S
    Minerva Chir; 1999 Oct; 54(10):657-67. PubMed ID: 10575887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques.
    May A; Gossner L; Pech O; Müller H; Vieth M; Stolte M; Ell C
    Endoscopy; 2002 Aug; 34(8):604-10. PubMed ID: 12173079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study.
    Conio M; Blanchi S; Lapertosa G; Ferraris R; Sablich R; Marchi S; D'Onofrio V; Lacchin T; Iaquinto G; Missale G; Ravelli P; Cestari R; Benedetti G; Macrì G; Fiocca R; Munizzi F; Filiberti R
    Am J Gastroenterol; 2003 Sep; 98(9):1931-9. PubMed ID: 14499768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surveillance of patients with Barrett's esophagus].
    Endlicher E; Knüchel R; Messmann H
    Z Gastroenterol; 2001 Aug; 39(8):593-600. PubMed ID: 11558064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
    Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
    Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of endoscopy surveillance for Barrett's oesophagus.
    Bright T; Schloithe A; Bull JA; Fraser RJ; Bampton P; Watson DI
    ANZ J Surg; 2009 Nov; 79(11):812-6. PubMed ID: 20078532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic screening and surveillance for Barrett's esophagus--clinical implications.
    Barr H; Kendall C; Bazant-Hegemark F; Moayyedi P; Shetty G; Stone N
    MedGenMed; 2006 Jun; 8(2):66. PubMed ID: 16926805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barrett's esophagus: the role of laparoscopic fundoplication.
    Abbas AE; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Miller DL; Pairolero PC
    Ann Thorac Surg; 2004 Feb; 77(2):393-6. PubMed ID: 14759403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus.
    Pohl H; Rösch T; Vieth M; Koch M; Becker V; Anders M; Khalifa AC; Meining A
    Gut; 2008 Dec; 57(12):1648-53. PubMed ID: 18755886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New advances in the diagnosis and treatment of early onset dysplasia and adenocarcinoma in Barrett's oesophagus].
    Pera M; Grande L; Iglesias M; Ramón JM; Conio M
    Cir Esp; 2009 Jun; 85(6):331-40. PubMed ID: 19463990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.